This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
YUM! Brands (YUM) fits the millennial portfolio. The company claims two top 100 spots in the 'millennials favorite brands' list. Management is shareholder friendly and has a clear goal of increasing the ownership of existing shareholders by buyback programs. YUM! Brands' management shot the arrow exactly in the bull's eye with its partnership with Grubhub (GRUB). I prefer YUM! Brands over YUM China (YUMC) because it offers more diversity while still getting a license fee from its former Chinese subsidiary.
YUM GRUB MCD
FirstEnergy Corp’s (FE - Free Report) subsidiary — Jersey Central Power & Light (JCP&L) — has sought approval from the New Jersey Board of Public Utilities (BPU) for a four-year infrastructure plan, Reliability Plus. To improve the reliability and service quality for its 1.1 million electric customers in New Jersey, the company will spend $400 million, which is more than planned annual investments.
NI DUKH YUM NTRS GTT NTRSP DUK BKHU FE BKH
In business and in life, you are allowed leeway for certain mistakes. But some unforced errors are not only inexcusable, they are intractably damaging, perhaps crippling. Papa John’s (NASDAQ:PZZA) founder John Schnatter found this out the hard way. Inexplicably, Schnatter used the N-word during a May conference call. His subsequent admission and apology cratered PZZA stock.
YUM MCD PZZA
Yum! Brands (NYSE:YUM) has announce that it is bringing back Taco Bell Nacho Fries in a big way as the company has rolled out a fake movie trailer.
YUM! Brands, Inc.’s (YUM - Free Report) subsidiary, Pizza Hut, has extended its agreement with the NCAA, which commenced in 2016. Per the deal, Pizza Hut will continue to be the Official Pizza of the NCAA through the 2020-2021 academic year. Currently, YUM! Brands has the rights to all 90 championships for games like basketball, hockey, bowling, fencing, baseball and beach volleyball.
YUM FRSH WING TAST
Darden Restaurants, Inc.’s (DRI - Free Report) effective sales-boosting initiatives and synergies from Cheddar’s acquisition put the company on growth trajectory. However, high costs related to restaurant operations and stiff competition remain major concerns.
YUM DRI MCD
FirstEnergy Corp’s (FE - Free Report) subsidiary — Potomac Edison — will build substation near Foxville. The unit will also rebuild six miles of 12-kilovolt (kV) distribution line which will connect Wolfsville, Maryland and the substation. This $4-million project is part of Potomac Edison’s $156-million investment planned for 2018 to upgrade and strengthen distribution and transmission infrastructure Focus on Transmission and Distribution Lines A proper network of transmission and distribution lines enables utility operators to serve customers more efficiently and effectively.
XEL YUM CMSA ADI PPL CMS FE
I was a skeptic toward McDonald’s (NYSE:MCD) for some time. MCD stock took off in late 2015, not long after CEO Steve Easterbrook took over. MCD bulls pointed to strong same-restaurant sales numbers. But I argued through 2016 that the seeming improvement under Easterbrook was coming from easy year-prior comparisons, not necessarily a massive improvement in the business.
LW YUM KO MCD DPZ
In 2016, global fast food giant Yum! Brands, Inc. (NYSE:YUM) split its business into two: Yum China Holdings Inc (NYSE:YUMC) and Yum operations everywhere else. Since then, Yum China stock has been the big out-performer.
It has been a volatile year for the Retail-Food & Restaurants industry so far. Year to date, the industry has declined 4% against the S&P 500’s 1.7% gain. Under such circumstances, Cracker Barrel Old Country Store, Inc. (CBRL - Free Report) , which has witnessed its shares rise more than 670% in the last 10 years, is trading sideways in 2018. Even though the company looks promising on its efficient cost-saving initiatives, higher labor costs and expenses related to various sales-boosting initiatives are weighing on its margins.
Black Hills Corp.‘s (BKH - Free Report) natural gas utility subsidiary announced that it has submitted a 35-mile natural gas pipeline construction proposal to the Wyoming Public Service Commission (WPSC) in the month of May 2018. The extended Natural Bridge Pipeline will supply additional volumes of natural gas to provide efficient services to customers in Wyoming. The new 12-inch steel pipeline will be connected with the 750-mile transmission pipeline system which serves the Riverton and Casper areas.
NI DUKH YUM DUK BKHU FE BKH
Brian Niccol, given credit for the rise of Taco Bell within Yum! Brands (NYSE:YUM), is rolling out similar plans for Chipotle (NYSE:CMG) and analysts aren’t buying it.
YUM MCD CMG
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to YUM / Yum! Brands, Inc. on message board site Silicon Investor.
|ChickenButt doing the Wild Thang.||Tricon (YUM)|
as of ET